Qube Research & Technologies (QRT)
MLYS icon

Qube Research & Technologies (QRT)’s Mineralys Therapeutics MLYS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8M Buy
914,728
+418,179
+84% +$12.3M 0.03% 765
2025
Q4 		$18M Buy
496,549
+316,123
+175% +$12.7M 0.02% 970
2025
Q3 		$6.84M Sell
180,426
-170,687
-49% -$3.69M 0.01% 1547
2025
Q2 		$4.75M Buy
+351,113
New +$5.09M ﹤0.01% 1735
2024
Q2 		– Sell
-1,025
Closed -$13.2K – 4400
2024
Q1 		$13.2K Buy
1,025
+301
+42% +$3.72K ﹤0.01% 3763
2023
Q4 		$6.23K Buy
724
+261
+56% +$2.05K ﹤0.01% 3684
2023
Q3 		$4.4K Buy
+463
New +$6.04K ﹤0.01% 3471

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MLYS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Mineralys Therapeutics (MLYS) stake by 84% in Q1 2026, buying an estimated $12.3M and bringing the position to 914,728 shares worth $24.8M. The position accounts for 0.03% of the portfolio, ranked #765.

Qube Research & Technologies (QRT) first reported a position in MLYS in Q3 2023 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 914,728 shares of Mineralys Therapeutics worth $24.8M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 418,179 Mineralys Therapeutics shares in Q1 2026, an estimated $12.3M.
  • Mineralys Therapeutics made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #765 holding.
  • Qube Research & Technologies (QRT) first reported a position in Mineralys Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.